Saudi Arabian healthcare provider, reportedly experiencing robust growth across multiple departments, anticipates positive results for the third quarter of 2025.
During a recent meeting with analysts and investors, company executive Al-Mousa detailed broad-based growth encompassing surgery, primary care, rehabilitation, hematology, oncology, neuroscience, and orthopedics. This diversification is credited with bolstering overall company performance. Specifically, July – the initial month of the third quarter – saw particularly strong gains in the rehabilitation sector, alongside increased utilization of surgical services and a rise in patient volume, defying typical seasonal dips associated with summer vacations.
Financial data presented indicated a 15.4% increase in inpatient numbers, reaching 10,000 patients, during the second quarter of 2025. Outpatient clinic visits rose by 13.2% to 287,100 during the same period.
The company is actively pursuing expansion initiatives. The 6,100 square meter “Palm Medical Center” opened in Al-ahsa in July 2025, housing 37 clinics. Construction is nearing completion on additional facilities: the “Aziziyah Medical Center” in Al-Khobar and the “Salmaniya Medical Center,” also located in Al-Ahsa. These expansions represent a significant investment in healthcare infrastructure within the Eastern Province of Saudi Arabia.
